Please use this identifier to cite or link to this item:
Title: Treatment of monilethrix with oral minoxidil.
Epworth Authors: Sinclair, Rodney
Keywords: Hair Loss
Hair Fragility
Hair Shaft Disorder
Hereditary Hair Loss
Hereditary Alopecia
Department of Dermatology, Epworth HealthCare, Victoria, Australia
Head & Neck Clinical Institute, Epworth HealthCare, Victoria, Australia
Issue Date: 2016
Publisher: Elsevier
Citation: JAAD Case Rep. 2016 May 26;2(3):212-5.
Abstract: Monilethrix is an autosomal dominant genodermatosis characterized by hair fragility, keratosis pilaris, and pathognomonic beading of the hair shaft. Hair fragility may lead to hair breakage and the appearance of generalized hair loss. Oral minoxidil is a promising treatment for hair loss associated with monilethrix. When used in low doses it appears to be well tolerated. Based on observations in male and female pattern hair loss, it is likely that that long-term maintenance treatment will be required to prevent relapse of hair loss. Further studies are required to document safety and efficacy.
DOI: 10.1016/j.jdcr.2016.02.011
PubMed URL:
ISSN: 2352-5126
Journal Title: JAAD Case Reports
Type: Journal Article
Affiliated Organisations: Department of Medicine, University of Melbourne, Victoria, Australia
Type of Clinical Study or Trial: Review
Appears in Collections:Dermatology
Head & Neck

Files in This Item:
There are no files associated with this item.

Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.